Erratum: Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced qacute renal failure (Kidney International (2007) 71 (538-546) DOI:10.1038/sj.ki.5002104);Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced qacute renal failure

Kidney International

Volumn 71, Issue 6, 2007, Pages 539-547

  Matsuzaki, T ^a   Watanabe, H ^a   Yoshitome, K ^a   Morisaki, T ^a   Hamada, A ^a   Nonoguchi, H ^b   Kohda, Y ^b   Tomita, K ^b   Inui, K ^c   Saito, H ^a  

^a KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute renal failure; Cobalt chloride; Indoxyl sulfate; Ischemia reperfusion; Organic anion transporter

Indexed keywords

4 AMINOHIPPURIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); COBALT CHLORIDE; ESTRONE SULFATE; INDICAN; MESSENGER RNA; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; KIDNEY ISCHEMIA; KIDNEY SLICE; KIDNEY TUBULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 33947114449     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002216     Document Type: Erratum

References (37)

1. Inui K, Masuda S, Saito H. Cellular and molecular aspects of drug transport in the kidney. Kidney Int 2000; 58: 944-958.
2. Pritchard JB, Miller DS. Renal secretion of organic anions and cations. Kidney Int 1996; 49: 1649-1654.
3. Ullrich KJ. Specificity of transporters for 'organic anions' and 'organic cations' in the kidney. Biochim Biophys Acta 1994; 1197: 45-62.
4. Sekine T, Cha SH, Endou H. The multispecific organic anion transporter (OAT) family. Pflugers Arch 2000; 440: 337-350.
5. Sweet DH, Pritchard JB. The molecular biology of renal organic anion and organic cation transporters. Cell Biochem Biophys 1999; 31: 89-118.
6. Mizuno N, Niwa T, Yotsumoto Y et al. Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 2003; 55: 425-461.
7. Schrier RW, Wang W, Poole B et al. Acute renal failure: definitions diagnosis pathogenesis and therapy. J Clin Invest 2004; 114: 5-14.
8. Star RA. Treatment of acute renal failure. Kidney Int 1998; 54: 1817-1831.
9. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334: 1448-1460.
10. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210.
11. Shanley PF, Rosen MD, Brezis M et al. Topography of focal proximal tubular necrosis after ischemia with reflow in the rat kidney. Am J Pathol 1986; 122: 462-468.
12. Lieberthal W, Nigam SK. Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol 1998; 275: F623-F631.
13. Matsumoto M, Makino Y, Tanaka T et al. Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 2003; 14: 1825-1832.
14. Wang GL, Jiang BH, Rue EA et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514.
15. Maxwell P. HIF-1: an oxygen response system with special relevance to the kidney. J Am Soc Nephrol 2003; 14: 2712-2722.
16. Iyer NV, Kotch LE, Agani F et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998; 12: 149-162.
17. Comerford KM, Wallace TJ, Karhausen J et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 2002; 62: 3387-3394.
18. Niwa T, Nomura T, Sugiyama S et al. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int 1997; 52(Suppl 62): S23-S28.
19. Niwa T, Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994; 124: 96-104.
20. Enomoto A, Takeda M, Tojo A et al. Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol 2002; 13: 1711-1720.
21. Deguchi T, Ohtsuki S, Otagiri M et al. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney Int 2002; 61: 1760-1768.
22. Aoyama I, Enomoto A, Niwa T. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis. Am J Kidney Dis 2003; 41: S8-S14.
23. Deguchi T, Takemoto M, Uehara N et al. Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats. J Pharmacol Exp Ther 2005; 314: 932-938.
24. Sakurai Y, Motohashi H, Ueo H et al. Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm Res 2004; 21: 61-67.
25. Kwon TH, Frokiaer J, Han JS et al. Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure. Am J Physiol Renal Physiol 2000; 278: F925-F939.
26. Van Why SK, Mann AS, Ardito T et al. Expression and molecular regulation of Na(+)-K(+)-ATPase after renal ischemia. Am J Physiol 1994; 267: F75-F85.
27. Kribben A, Edelstein CL, Schrier RW. Pathophysiology of acute renal failure. J Nephrol 1999; 12(Suppl 2): S142-S151.
28. Molitoris BA, Dahl R, Geerdes A. Cytoskeleton disruption and apical redistribution of proximal tubule Na(+)-K(+)-ATPase during ischemia. Am J Physiol 1992; 263: F488-F495.
29. Miyazaki T, Ise M, Seo H et al. Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys. Kidney Int 1997; 52(Suppl 62): S15-S22.
30. Miyazaki T, Aoyama I, Ise M et al. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol Dial Transplant 2000; 15: 1773-1781.
31. Sakai T, Maruyama T, Imamura H et al. Mechanism of stereoselective serum binding of ketoprofen after hemodialysis. J Pharmacol Exp Ther 1996; 278: 786-792.
32. Deguchi T, Kusuhara H, Takadate A et al. Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int 2004; 65: 162-174.
33. Sweet DH, Wolff NA, Pritchard JB. Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem 1997; 272: 30088-30095.
34. Sweet DH, Chan LM, Walden R et al. Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient. Am J Physiol Renal Physiol 2003; 284: F763-F769.
35. Sweet DH. Organic anion transporter (Slc22a) family members as mediators of toxicity. Toxicol Appl Pharmacol 2005; 204: 198-215.
36. Huang ZH, Murakami T, Okochi A et al. Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure. Eur J Pharmacol 2000; 406: 453-460.
37. Habu Y, Yano I, Takeuchi A et al. Decreased activity of basolateral organic ion transports, in hyperuricemic rat kidney: roles of organic ion transporters rOAT1, rOAT3 and rOCT2. Biochem Pharmacol 2003; 66: 1107-1114.